Angioimmunoblastic Lymphadenopathy
- 1 January 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 114 (1) , 92-94
- https://doi.org/10.1001/archderm.1978.01640130056016
Abstract
• Angioimmunoblastic lymphadenopathy (AIBL) is a recently described, systemic disorder characterized by an excessive proliferation of transformed lymphocytes, possibly the result of chronic antigenic stimulation, frequently by drugs. Cutaneous involvement, usually in the form of a pruritic, generalized, maculopapular rash, occurs in about 40% of cases. We saw a patient with AIBL who had an unusual, primarily plaque- and nodular-type of skin involvement and who had been receiving drugs not previously reported as being associated with this disorder. Because cutaneous involvement is a frequent, presenting complaint, dermatologists should be able to recognize this unusual, clinicopathologic entity. (Arch Dermatol 114:92-94, 1978)Keywords
This publication has 2 references indexed in Scilit:
- Angioimmunoblastic lymphadenopathyPublished by Springer Nature ,2011
- Angio-immunoblastic lymphadenopathy. Diagnosis and clinical courseThe American Journal of Medicine, 1975